Patient Information:
	•Name: Denise Curry
	•Date of Birth: 01/01/1975
	•Medical Record Number: M1021
	•Date of Admission: 05/02/2023
	•Date of Discharge: 15-03-2023
	•Attending Physician: Dr. Janessa White
	•Primary Diagnosis: Pancreatic Cancer (Stage III) with Surgical Resection and Adjuvant Chemotherapy

Reason for Admission:
	Denise Curry, a 48-year-old male, was admitted to the hospital due to persistent abdominal pain, jaundice, and unexplained weight loss over several months. Initial assessments revealed elevated liver enzymes, anemia, and a palpable mass in the epigastric region. Subsequent diagnostic tests including CT scan, MRI, and endoscopic ultrasound confirmed the presence of a 4cm x 5cm tumor in the pancreatic head, with involvement of the superior mesenteric artery and portal vein, suggestive of Denise Curry Denise Curry.

Medical History:
	Denise Curry has a significant past medical history, including hypertension, diabetes mellitus type 2, and Chronic Obstructive Pulmonary Disease (COPD). He underwent a right total knee replacement surgery 5 years ago. His family history is notable for breast cancer in his mother and colon cancer in his father. Allergies include penicillin and sulfa drugs. Pre-admission medications included metformin, lisinopril, atorvastatin, salmeterol/fluticasone, and ibuprofen.

Diagnostic Findings:
	Pathology report confirmed the presence of adenocarcinoma in the pancreatic head. CA 19-9 levels were elevated at 250 U/ml (normal range <37 U/ml). CT scan with contrast revealed the primary tumor, local lymph node involvement, and metastasis to the liver.

Treatment Plan:
	A multidisciplinary team of oncologists, surgeons, and radiotherapists developed a comprehensive treatment plan for Mr. Curry. The initial approach involved surgical resection of the pancreatic tumor followed by adjuvant chemotherapy. The surgery was successfully performed, with a Whipple procedure (pancreatoduodenectomy) to remove the tumor and adjacent tissues. Post-operative care included pain management, nutritional support via total parenteral nutrition (TPN), and close monitoring for complications such as leaks from anastomosis sites.

Hospital Course:
	

Follow-Up Plan:
	Denise Curry will be scheduled for regular follow-up appointments every 3 months during the first year, then every 6 months thereafter. Continuation of Gemcitabine and Abraxane is recommended for six cycles, followed by maintenance therapy with Gemcitabine alone. A strict dietary regimen focusing on small, frequent meals will be advised to manage his diabetes and promote weight gain. Lifestyle modifications including quitting smoking (if applicable) and regular exercise are essential for improving his overall health.

Patient Education:
	Detailed education was provided to Denise Curry and his family regarding the treatment plan, post-surgical care, signs of complications, and management of common side effects such as nausea, fatigue, and neuropathy. Specific instructions were given on managing an ileal conduit, including emptying techniques, irrigation schedules, and monitoring for signs of infection or obstruction.

Discharge Instructions:
	Comprehensive discharge instructions were provided to Denise Curry focusing on medication adherence, wound care practices, hydration, and physical activity guidelines. He was advised to take his medications as prescribed, maintain a balanced diet, perform gentle exercises as tolerated, and monitor his weight regularly. Instructions for home care included proper wound dressing changes, signs of infection, and when to seek immediate medical attention.

Prognosis and Long-Term Outlook:
	The prognosis for Denise Curry Denise Curry is generally poor, with a 5-year survival rate of around 10%. However, regular monitoring for early detection of recurrence and managing ongoing health issues will be crucial in improving his chances of long-term survival.

Final Remarks:
	I commend Denise Curry for his resilience and cooperation throughout the treatment journey. He has shown remarkable determination and dedication to his recovery, which has been instrumental in achieving this milestone. This report serves as a testament to his bravery and the collaborative efforts of our team. I wish him all the best in his continued recovery.
